The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients
Abstract
Background and Purpose— The use of intravenous thrombolysis is restricted to a minority of patients by the rigid 3-hour time window. This window may be extended by using modern imaging-based selection algorithms. We assessed safety and efficacy of MRI-based thrombolysis within and beyond 3 hours compared with standard CT-based thrombolysis. Methods— Five European stroke centers pooled the core data of their CT- and MRI-based prospective thrombolysis databases. Safety outcomes were predefined as symptomatic intracranial hemorrhage and mortality. Primary efficacy outcome was a favorable outcome (modified Rankin Scale 0 to 1). We performed univariate and multivariate analyses for all end points, including age, National Institutes of Health Stroke Scale, treatment group (CT <3 hours, MRI <3 hours and >3 hours), and onset to treatment time as variables. Results— A total of 1210 patients were included (CT <3 hours: N=714; MRI <3 hours: N=316; MRI >3 hours: N=180). Median age, National Institutes of Health Stroke Scale, and onset to treatment time were 69, 67, and 68.5 years ( P =0.66); 12, 13, and 14 points ( P =0.019); and 130, 135, and 240 minutes ( P <0.001). Symptomatic intracranial hemorrhage rates were 5.3%, 2.8%, and 4.4% ( P =0.213); mortality was 13.7%, 11.7%, and 13.3% ( P =0.68). Favorable outcome occurred in 35.4%, 37.0%, and 40% ( P =0.51). Age and National Institutes of Health Stroke Scale were independent predictors for all safety and efficacy outcomes. The overall use of MRI significantly reduced symptomatic intracranial hemorrhage (OR: 0.520, 95% CI: 0.270 to 0.999, P =0.05). Beyond 3 hours, the use of MRI significantly predicted a favorable outcome (OR: 1.467; 95% CI: 1.017 to 2.117, P =0.040). Within 3 hours and for all secondary end points, there was a trend in favor of MRI-based selection over standard <3-hour CT-based treatment. Conclusion— Despite significantly longer time windows and significantly higher baseline National Institutes of Health Stroke Scale scores, MRI-based thrombolysis is safer and potentially more efficacious than standard CT-based thrombolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial
Smith, W. S., Sung, G., Starkman, S., Saver, J. L., Kidwell, C. S., Gobin, Y. P., Lutsep, H. L., Nesbit, G. M., Grobelny, T., Rymer, M. M., et al. (2005) · Stroke · doi:10.1161/01.str.0000171066.25248.1d · Cited by 1,312
Chalela, J. A., Kidwell, C. S., Nentwich, L. M., Luby, M., Butman, J. A., Demchuk, A. M., Hill, M. D., Patronas, N., Latour, L., & Warach, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60151-2 · Cited by 1,301
Albers, G. W., Thijs, V. N., Wechsler, L., Kemp, S., Schlaug, G., Skalabrin, E., Bammer, R., Kakuda, W., Lansberg, M. G., Shuaib, A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20976 · Cited by 1,268
Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
Why are stroke patients excluded from TPA therapy?: An analysis of patient eligibility
Barber, P. A., Zhang, J., Demchuk, A. M., Hill, M. D., & Buchan, A. M. (2001) · Neurology · doi:10.1212/wnl.56.8.1015 · Cited by 704
European Stroke Initiative Recommendations for Stroke Management – Update 2003
(2003) · Cerebrovascular Diseases · doi:10.1159/000072554 · Cited by 635
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Fiebach, J. B., Schellinger, P. D., Jansen, O., Meyer, M., Wilde, P., Bender, J., Schramm, P., Jüttler, E., Oehler, J., Hartmann, M., et al. (2002) · Stroke · doi:10.1161/01.str.0000026864.20339.cb · Cited by 507
Self-citationAntithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Hill, M. D. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041561 · Cited by 452
Fiebach, J. B., Schellinger, P. D., Gass, A., Kucinski, T., Siebler, M., Villringer, A., Ölkers, P., Hirsch, J. G., Heiland, S., Wilde, P., et al. (2004) · Stroke · doi:10.1161/01.str.0000114203.75678.88 · Cited by 434
Self-citationEffect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours
Röther, J., Schellinger, P. D., Gass, A., Siebler, M., Villringer, A., Fiebach, J. B., Fiehler, J., Jansen, O., Kucinski, T., Schoder, V., et al. (2002) · Stroke · doi:10.1161/01.str.0000030109.12281.23 · Cited by 326
Self-citationImaging-based decision making in thrombolytic therapy for ischemic stroke: present status.
Schellinger, P. D., Fiebach, J. B., & Hacke, W. (2003) · PubMed · Cited by 278
Self-citationImportance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study
Demchuk, A. M., Hill, M. D., Barber, P. A., Silver, B., Patel, S. C., & Levine, S. R. (2005) · Stroke · doi:10.1161/01.str.0000181116.15426.58 · Cited by 269
Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
Jansen, O., Schellinger, P., Fiebach, J., Hacke, W., & Sartor, K. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01146-0 · Cited by 258
Self-citationSobesky, J., Weber, O. Z., Lehnhardt, F.-G., Hesselmann, V., Neveling, M., Jacobs, A., & Heiss, W.-D. (2005) · Stroke · doi:10.1161/01.str.0000160751.79241.a3 · Cited by 248
Self-citationImaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status
Schellinger, P. D., Fiebach, J. B., & Hacke, W. (2003) · Stroke · doi:10.1161/01.str.0000051504.10095.9c · Cited by 241
Self-citationThomalla, G., Schwark, C., Sobesky, J., Bluhmki, E., Fiebach, J. B., Fiehler, J., Zaro Weber, O., Kucinski, T., Juettler, E., Ringleb, P. A., et al. (2006) · Stroke · doi:10.1161/01.str.0000204120.79399.72 · Cited by 235
Self-citationKöhrmann, M., Jüttler, E., Fiebach, J. B., Huttner, H. B., Siebert, S., Schwark, C., Ringleb, P. A., Schellinger, P. D., & Hacke, W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70499-9 · Cited by 230
Self-citationMagnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Hjort, N., Butcher, K., Davis, S. M., Kidwell, C. S., Koroshetz, W. J., Röther, J., Schellinger, P. D., Warach, S., & Østergaard, L. (2005) · Stroke · doi:10.1161/01.str.0000152268.47919.be · Cited by 214
Self-citationSobesky, J., Weber, O. Z., Lehnhardt, F.-G., Hesselmann, V., Thiel, A., Dohmen, C., Jacobs, A., Neveling, M., & Heiss, W.-D. (2004) · Stroke · doi:10.1161/01.str.0000147043.29399.f6 · Cited by 177
Self-citationAbciximab Emergent Stroke Treatment Trial (AbESTT) Investigators (2005) · Stroke · doi:10.1161/01.str.0000157668.39374.56 · Cited by 160
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Kang, D., Chalela, J. A., Dunn, W., & Warach, S. J. (2005) · Stroke · doi:10.1161/01.str.0000177539.72071.f0 · Cited by 100
Cited by
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Davis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., Barber, P. A., Bladin, C., De Silva, D. A., Byrnes, G., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70044-9 · Cited by 1,052
Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2
Mittal, S., Wu, Z., Neelavalli, J., & Haacke, E. M. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1461 · Cited by 769
Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study
Wahlgren, N., Ahmed, N., Dávalos, A., Hacke, W., Millán, M., Muir, K., Roine, R. O., Toni, D., & Lees, K. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61339-2 · Cited by 569
Diffusion MRI at 25: exploring brain tissue structure and function
Le Bihan, D., & Johansen-Berg, H. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.006 · Cited by 498
Metadata
- Authors
- Schellinger, P. D., Thomalla, G., Fiehler, J., Köhrmann, M., Molina, C. A., Neumann-Haefelin, T., Ribo, M., Singer, O. C., Zaro-Weber, O., & Sobesky, J.
- Venue
- Stroke
- Published
- 2007-10
- Volume
- 38
- Issue
- 10
- Pages
- 2640-2645
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2149646320
- Cited by
- 264
- References
- 28
- FWCI
- 25.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.